More than 11,000 bottles are affected.
- The FDA recalled chlorthalidone tablets due to “failed dissolution specifications.”
- Over 11,000 bottles of the blood pressure medication are impacted nationwide.
- Check your medication and contact your pharmacy if it matches the recall details.
There’s an active recall on blood pressure medication prescribed and sold nationwide, according to the U.S. Food and Drug Administration (FDA). Per the announcement, this is due to “failed dissolution specifications.”
The medication being recalled is 100- and 1,000-count bottles of 25-milligram chlorthalidone tablets distributed by Risiong Pharma Holdings, Inc., across the U.S. The 100-tablet bottles are labeled with the code 64980-599-01 and batch number RISA24001, whereas the affected 1,000-tablet bottles have code 64980-599-10 and batch number RISB24002 on the bottle. All impacted products have a printed expiration date of “04/2027” on the packaging.
Approximately 11,460 bottles of chlorthalidone are affected by this recall. Check your medication, and if it matches the above information, contact your pharmacy for a potential replacement or refund.
Chlorthalidone is a common medication used for regulating high blood pressure and to treat fluid retention. While the recall has yet to be classified, seek medical attention if you are experiencing any health concerns after consuming the recalled tablets.
Comments are closed.